Company / Cash per Share
BioLife Solutions, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.68
FY2025
5-year range
$0.45 / $1.99
FY2021-FY2025
Trend
-65.8%
vs FY2024
Sector context
#132 of 150
Health Care
What the data says
BioLife Solutions, Inc.'s cash per share of $0.68 is lower than 88% of companies in the Health Care sector (FY2025). Cash per Share has fluctuated over the past 10 years, ranging from $0.11 in FY2016 to $3.31 in FY2020.
Based on SEC 10-K filings.
0.68 in FY2025 with a 5-year CAGR of -27.2%.
Improved from $0.64 to $0.68 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +14.6%
- 5-Year CAGR
- -27.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 150This company $0.68 Sector average $27.11
▼
-97.5% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 65.8% year-over-year.
- Ranks #132 out of 150 companies in the Health Care sector.
- Peak cash per share was recorded in FY2020.
- Lowest cash per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.68 | -65.8% |
| FY2024 | $1.99 | +211.4% |
| FY2023 | $0.64 | +41.4% |
| FY2022 | $0.45 | -75.1% |
| FY2021 | $1.81 | -45.2% |
| FY2020 | $3.31 | +899.2% |
| FY2019 | $0.33 | -31.0% |
| FY2018 | $0.48 | -7.3% |
| FY2017 | $0.52 | +358.6% |
| FY2016 | $0.11 | -37.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026